“The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 15, no. 1S, Dec. 2014, pp. 3-4, https://doi.org/10.7175/fe.v15i1s.972.